Hello,
I'm studying common gene copy number alterations found in 4 cell lines that are sensitive to a drug we are testing.
The lines are:
MV411, AML from a male patient
Hep3b2.1-7, liver cancer from a male patient
CAPAN1, pancreatic cancer from a male patient, and
AU-565, HER2 + breast cancer from a female patient.
We found 50 common genes with copy number alterations in these 4 lines. In order to weed out possible genes that may not have any connection to the sensitivity, I looked at TTTY genes, of which there were 12. In researching these, I found that they are all
on the Y chromosome, which was puzzling as they were even present in the female line. Looking more in depth, I found that 44 out of the 50 genes were from Y chromosome.
I looked at other breast cancer lines, (8 total, from female patients): MDA-MB-231, MDA-MB-157, MCF7, BT-20, HCC1419, HCC1954, and HCC1569. We also checked 5 ovarian lines: OVCAR3, OVCAR4, OVCAR5, OVCAR8, and SKOV3. All had multiple TTTY genes that with CNAs,
(all deep deletions).
I was hoping you could shed some light on this. Any information or ideas you could share with me would be greatly appreciated.
Two ideas that we discussed were:
Contamination with a male cell line, but this seemed unlikely to have happened to so many lines.
Misidentification of the genes, as they were deep deleted and may have identified a short sequence of an analogous female gene.
Also, do you have access to the original sequencing data files that you could share with us?
Thanks for any assistance you can provide.
Sincerely,
Steve Rocca